全文获取类型
收费全文 | 6767篇 |
免费 | 507篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 169篇 |
妇产科学 | 137篇 |
基础医学 | 1034篇 |
口腔科学 | 128篇 |
临床医学 | 589篇 |
内科学 | 1702篇 |
皮肤病学 | 106篇 |
神经病学 | 689篇 |
特种医学 | 158篇 |
外科学 | 1104篇 |
综合类 | 45篇 |
一般理论 | 4篇 |
预防医学 | 451篇 |
眼科学 | 154篇 |
药学 | 381篇 |
中国医学 | 15篇 |
肿瘤学 | 393篇 |
出版年
2023年 | 56篇 |
2022年 | 106篇 |
2021年 | 208篇 |
2020年 | 129篇 |
2019年 | 198篇 |
2018年 | 178篇 |
2017年 | 145篇 |
2016年 | 172篇 |
2015年 | 185篇 |
2014年 | 274篇 |
2013年 | 369篇 |
2012年 | 472篇 |
2011年 | 536篇 |
2010年 | 258篇 |
2009年 | 233篇 |
2008年 | 395篇 |
2007年 | 435篇 |
2006年 | 393篇 |
2005年 | 376篇 |
2004年 | 372篇 |
2003年 | 331篇 |
2002年 | 309篇 |
2001年 | 42篇 |
2000年 | 28篇 |
1999年 | 40篇 |
1998年 | 37篇 |
1997年 | 48篇 |
1996年 | 36篇 |
1995年 | 28篇 |
1994年 | 31篇 |
1993年 | 26篇 |
1992年 | 33篇 |
1991年 | 36篇 |
1990年 | 31篇 |
1989年 | 24篇 |
1988年 | 34篇 |
1986年 | 28篇 |
1985年 | 21篇 |
1984年 | 30篇 |
1983年 | 24篇 |
1982年 | 31篇 |
1981年 | 31篇 |
1980年 | 17篇 |
1978年 | 19篇 |
1977年 | 18篇 |
1975年 | 17篇 |
1974年 | 19篇 |
1973年 | 14篇 |
1964年 | 15篇 |
1962年 | 14篇 |
排序方式: 共有7308条查询结果,搜索用时 15 毫秒
41.
Fred De Clerck Ludo Van Gorp Oscar Vanparijs Marcel Borger Frans Awouters 《Inflammation research》1978,8(6):568-571
Infection withTrichinella spiralis in mice was accompanied by allergic sensitization as evidenced by anaphylactic death after intravenous injection of the antigen. Pre-treatment of the animals with oxatomide, a new orally active antiallergic drug, resulted in significant protection of the animals; the lowest effective dose of the compound was 1.25 mg/kg orally. In contrast to cyproheptadine, oxatomide offered little protection against serotonin toxicity in mice.The present data suggest that, in this model of systemic hypersensitivity, the anti-anaphylactic effect of oxatomide can be attributed mainly to inhibition of release of allergic mediators. 相似文献
42.
Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action 总被引:2,自引:0,他引:2
P Vadas W Pruzanski E Stefanski L G Ellies J E Aubin A Sos A Melcher 《Immunology letters》1991,28(3):187-193
Inflammatory processes are characterized by increased levels of extracellular phospholipase A2 (PLA2) and cytokines such as interleukin 1 (IL-1) and tumour necrosis factor (TNF). IL-1, TNF and PLA2 share a number of proinflammatory, arthritogenic effects. The sequential induction, first of the cytokines followed by PLA2, suggests that these cytokines may regulate synthesis and secretion of PLA2. To test this postulate, foetal rat calvarial bone-forming cells (FRCC) were treated with recombinant human IL-1 and TNF and extracellular PLA2 release was quantitated. Both IL-1 and TNF induced the de novo synthesis of PLA2 in a concentration-dependent manner. Continuous exposure of FRCC in primary culture to IL-1 (50 units/ml) over 15 days resulted in as much as 100-fold increase in PLA2 secretion. IL-1 (50 units/ml) added to post-confluent cultures for a 48-h pulse increased PLA2 activity 9.4-fold. The combination of IL-1 (50 units/ml) and TNF (500 units/ml) was synergistic with an observed increase in extracellular PLA2 secretion of 146-fold following a 48-h pulse. Interleukin-6, alone or in combination with IL-1 or TNF, did not further enhance PLA2 synthesis of secretion. Cytokine-induced synthesis of PLA2 was inhibited 80% by 10 microM cycloheximide but not by dexamethasone over the range of 10(-6) to 10(-8) M. FRCC-derived PLA2 was neutral-active with a pH optimum of 6-7.5 and was calcium-dependent with optimal activity in the presence of 2-7 mM calcium. It had absolute 2-acyl specificity using micellar phosphatidylcholine.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
43.
Factors affecting the determination of threshold doses for allergenic foods: how much is too much? 总被引:15,自引:0,他引:15
Steve L Taylor Susan L Hefle Carsten Bindslev-Jensen S Allan Bock A Wesley Burks Lynn Christie David J Hill Arne Host Jonathan O'b Hourihane Gideon Lack Dean D Metcalfe Denise Anne Moneret-Vautrin Peter A Vadas Fabienne Rance Daniel J Skrypec Thomas A Trautman Ingrid Malmheden Yman Robert S Zeiger 《The Journal of allergy and clinical immunology》2002,109(1):24-30
BACKGROUND: Ingestion of small amounts of an offending food can elicit adverse reactions in individuals with IgE-mediated food allergies. The threshold dose for provocation of such reactions is often considered to be zero. However, because of various practical limitations in food production and processing, foods may occasionally contain trace residues of the offending food. Are these very low, residual quantities hazardous to allergic consumers? How much of the offending food is too much? Very little quantitative information exists to allow any risk assessments to be conducted by the food industry. OBJECTIVE: We sought to determine whether the quality and quantity of existing clinical data on threshold doses for commonly allergenic foods were sufficient to allow consensus to be reached on establishment of threshold doses for specific foods. METHODS: In September 1999, 12 clinical allergists and other interested parties were invited to participate in a roundtable conference to share existing data on threshold doses and to discuss clinical approaches that would allow the acquisition of that information. RESULTS: Considerable data were identified in clinical files relating to the threshold doses for peanut, cows' milk, and egg; limited data were available for other foods, such as fish and mustard. CONCLUSIONS: Because these data were often obtained by means of different protocols, the estimation of a threshold dose was very difficult. Development of a standardized protocol for clinical experiments to allow determination of the threshold dose is needed. 相似文献
44.
45.
46.
D Rodríguez-Pérez Oscar Sotolongo-Grau Ramón Espinosa Riquelme Oscar Sotolongo-Costa J Antonio Santos Miranda J C Antoranz 《Mathematical medicine and biology》2007,24(3):287-300
A cytokine-based periodic immunotherapy treatment is included in a model of tumour growth with a delay. The effects of dose schedule are studied in the case of a weak immune system and a growing tumour. We find the existence of 'metastable' states (that may last for tens of years) induced by the treatment and also potentially adverse effects of the dosage frequency on the stabilization of the tumour. These two effects depend on the delay between the tumour growth and the immune system response, the cytokine dose burden, and other parameters considered in the model. 相似文献
47.
48.
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. 总被引:2,自引:0,他引:2
Giuseppe Pelosi Aldo Scarpa Michela Manzotti Giulia Veronesi Lorenzo Spaggiari Filippo Fraggetta Oscar Nappi Elvira Benini Felice Pasini Davide Antonello Antonio Iannucci Patrick Maisonneuve Giuseppe Viale 《Modern pathology》2004,17(5):538-546
We investigated 27 pleomorphic carcinomas of the lung for exon 1 K-ras gene mutations using polymerase chain reaction-single-strand conformation polymophism analysis and direct sequencing. All pleomorphic carcinomas were biphasic, that is, composed of an adeno-, squamous- or large-cell-carcinomatous component associated with a spindle- and/or giant-cell component. Of 27 cases, six (22%) showed K-ras codon 12 mutations, which is a figure higher than that previously reported on in pure sarcoma-like pleomorphic carcinomas. Five tumors displayed the same mutation in both the epithelial and the sarcomatoid components, whereas in one tumor the mutation was restricted to the epithelial component. All mutations occurred in smokers, and were transversions, including GGT (glycine) to TGT (cysteine) change in two cases, to GCT (alanine) in two and to GTT (valine) in two. No significant relationships were found between the occurrence and type of mutations and patients' survival or any other clinicopathological variable, suggesting that K-ras mutations are early events in the development of these tumors. Our results indicate that most, though not all, biphasic pleomorphic carcinomas of the lung are monoclonal in origin, and that cigarette smoking may have a causative role in the development of K-ras alterations in these tumors, as all mutations are transversions. 相似文献
49.
Laura McGillis Nimish Mittal Daniel Santa Mina Joyce So Medha Soowamber Aliza Weinrib Leslie Soever Dmitry Rozenberg Louis Liu Yvonne Tse Joel Katz George S Charames Kieran Murphy Peter Vadas Maxwell P Slepian Scott Walsh Lindsay Wilson Arnon Adler Alyssa Franzese Laura Hussey Dayna‐Lynn Nevay Juan Guzman Hance Clarke 《American journal of medical genetics. Part A》2020,182(3):484-492
The new 2017 diagnostic criteria for hypermobile Ehlers–Danlos Syndrome (hEDS) provide a framework for diagnosing hEDS but are more stringent than the previous Villefranche criteria. Our clinical experience at the GoodHope EDS clinic was that the 2017 criteria left many highly symptomatic patients without a diagnosis of hEDS. We conducted a retrospective cohort study to confirm our clinic experience and assess the accuracy of the 2017 diagnostic criteria for hEDS in patients who had a previous hEDS diagnosis based on the Villefranche criteria. Our study found that 15% (n = 20 of 131) of patients with a prior diagnosis of hEDS met the 2017 diagnostic criteria, and many of the traits used to distinguish hEDS were not significantly more frequent in patients who met 2017 criteria versus those who did not. In both groups objective systemic manifestations were found less frequently than subjective systemic manifestations. Beighton score (BS) as assessed by primary care practitioner was found to be higher than assessment by EDS practitioner in 81% (n = 74 of 91) of cases. Generalized joint hypermobility was confirmed in only 46% (n = 51 of 111) of patients who had a previous diagnosis of hEDS. Higher BS did not correlate with increased number of systemic manifestations in our cohort. Common comorbidities of hEDS were found with similar frequency in those who met 2017 criteria and those who did not. Based on our cohort, the 2017 hEDS diagnostic criteria require refinement to improve its diagnostic accuracy. 相似文献
50.
Marta Zelazko Magda Carneiro-Sampaio Monica Cornejo De Luigi Diana Garcia De Olarte Oscar Porras Madrigal Renato Berrón Perez Agueda Cabello Marylin Valentin Rostan Ricardo U. Sorensen 《Journal of clinical immunology》1998,18(2):161-166
The Latin American Group for Primary Immunodeficiencies, formed in 1993, presently includes 12 countries. One goal was to study the frequency of primary immunodeficiencies in various regions of the American continent and to enhance knowledge about these diseases among primary-care physicians, as well as allergist–immunologists. Important for this purpose was the development of a registry of primary immunodeficiencies using a uniform questionnaire and computerized database. To date, eight countries have collected information on a total of 1428 patients. Predominantly antibody deficiencies were reported in 58% of patients, followed by cellular and antibody immunodeficiencies associated with other abnormalities in 18%, immunodeficiency syndromes associated with granulocyte dysfunction in 8%, phagocytic disorders in 9%, combined cellular and antibody immunodeficiencies in 5%, and complement deficiencies in 2% of patients. The information gathered from this initial analysis of data will serve to expand the patient database to more areas within participating countries and to new countries and to increase collaboration toward better diagnosis and treatment of these diseases. 相似文献